Jaspan Vita N, Hines George L
From the Division of Vascular Surgery, Department of Thoracic and Cardiovascular Surgery, Winthrop University Hospital, Mineola, NY.
Cardiol Rev. 2015 Sep-Oct;23(5):236-9. doi: 10.1097/CRD.0000000000000060.
Tissue-engineered vascular grafts (TEVGs) are currently being developed to overcome the limitations and complications associated with traditional synthetic grafts. This article aims to review the current status of research into the production and use of tissue-engineered grafts. TEVGs have a number of theoretical advantages over synthetic grafts. The results of animal and human studies have been promising, but more work must be done before TEVGs can replace traditional grafts.
目前正在研发组织工程血管移植物（TEVGs），以克服与传统合成移植物相关的局限性和并发症。本文旨在综述组织工程移植物生产和使用的研究现状。与合成移植物相比，组织工程血管移植物具有许多理论优势。动物和人体研究的结果很有前景，但在组织工程血管移植物能够取代传统移植物之前，还需要做更多的工作。
